Thanks Fourex, SI now saying pre-BLA meeting for HFrEF is in the second half of this year to discuss with the FDA on clinical data, potency data and manufacturing data. That's great news considering early this year he mentioned the meeting will likely take place next year.
Not much has changed on CLBP and the only information is the first dosage is this quarter, more information on the details of the CLBP trial would be nice to keep investors in the loop.
Cash balance end of Q1 was $76.4m USD
Cash spent during Q1 was $11.7m USD
So lets average it $12m USD per quarter, leaving us 6 quarters from end of Q1 before we run out of cash. We need to get Children GVHD approved ASAP with adults for label extension thereafter. I have a feeling we may need another capital raising Q4 2024/Q12025 unless we get a partnership.
once approved, page-29
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |